Previous Page  15 / 26 Next Page
Information
Show Menu
Previous Page 15 / 26 Next Page
Page Background

Page 54

conferenceseries

.com

Volume 5, Issue 7 (Suppl)

J Infect Dis Ther, an open access journal

ISSN: 2332-0877

Infection Prevention 2017

December 14-15, 2017

December 14-15, 2017 | Rome, Italy

13

th

World Congress on

INFECTION PREVENTION AND CONTROL

Prevalence of various Hepatitis C genotypes among chronic HCV patients in a private laboratory,

Tehran, Iran

Solmaz Agha Amiri

1

and

Najmeh Zarei

2

1

Danesh private laboratory, Tehran, Iran

2

Pasteur institute of Iran, Iran

Background:

Hepatitis C (HCV) is a public health problem in many part of the world. Since HCV has different genotypes that

showing different responses to treatment, determination of patient‘s HCV genotype is critical prior to the antiviral therapy. The

aim of this study was to determine the prevalence of various HCV genotypes among patients who were referred to a private

laboratory in Tehran.

Material & Methods:

100 patients with chronic Hepatitis was enrolled from 2012-2017. RNA was extracted using standard

commercial kits from patient’s serum. After cDNA synthesis, HCV RNA was detected using reverse transcriptase Nested-PCR

(RT-Nested PCR) and then HCV genotypes were determined with restriction fragment length polymorphism (RFLP) assay.

Results:

Out of 100 samples, 45 (45%) were positive for subtype 1a, and 41 (41%) were subtype 3a, followed by 11 (11%)

genotype 1b, and genotypes 2a, 2b and 4 were 1 (1%) each. There are no mixed HCV genotypes found in the patients.

Conclusion:

This study showed that the most frequent genotype among the patients in Tehran was 1a followed by 3a.

sulmaz.amiri@gmail.com

J Infect Dis Ther 2017, 5:7(Suppl)

DOI: 10.4172/2332-0877-C1-036